RNA-Seq Blog Transcriptome Research & Industry News
AUSTIN, Texas — Asuragen, Inc., a leading molecular diagnostic company, has been selected to work with the Early Diagnosis Consortium (EDC), a collaboration between Cancer Research UK, Cancer Research Technology, and Abcodia. The Consortium aims to discover and validate serum biomarkers ...
Read More »Asuragen to Join UK Cancer Research Consortium to Develop miRNA Based Sequencing Tests for Early Detection and Screening of Cancer
